30 March 2016
As a past president of the American Society of Hypertension, I am writing today to give you and your fellow clinicians an exceptionally good reason to attend the ASH Annual Scientific Meeting – May 13-17, 2016 in New York City: at this year’s meeting, we will be highlighting the landmark SPRINT Trial--including featuring some new SPRINT data being released for the first time.
I was a principal investigator of one of the five clinical networks involved in SPRINT, and I’m very excited to share the results of this study and its implications for patient care. In fact, because the results have been so outstandingly positive with respect to preventing cardiovascular disease outcomes and death in the study population, healthcare providers need to know how to treat and manage blood pressure more effectively … and the ASH Annual Scientific Meeting provides the perfect hypertension learning experience.
From the SPRINT Trial session, to sessions focused on how to use diuretics alone and in combination, to sessions on utilizing mobile health technology in blood pressure control, the ASH Annual Meeting will provide attendees with both the latest evidence in clinical hypertension research and the tools and skills for point of care application.
I would like to give you the opportunity both to hear from the experts, and to discuss with them, the implications of SPRINT – at our Annual Meeting in May. In fact I would say that if there ever was a BEST TIME to attend the ASH Annual Meeting – 2016 would be the year!
Please click on the following links (below) for more information about the ASH Annual Scientific Meeting and Exposition – May 13-17, 2016 – in New York City.
Suzanne Oparil, MD
Distinguished Professor of Medicine
Professor of Cell, Developmental and Integrative Biology
Director, Vascular Biology and Hypertension Program
Of the Division of Cardiovascular Disease
Department of Medicine
University of Alabama at Birmingham
to Sign up as an ATTENDEE for ASH 2016.
to learn more about the SPRINT STUDY and the results released so far.
Please download the letter below...